None
Quote | Annovis Bio Inc. (OTCMKTS:ANVS)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.015 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Annovis Bio Inc. (OTCMKTS:ANVS)
2024-05-17 06:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-15 10:01:12 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Health care is still very crowded but trades at a discount vs. history - BofA Health ca...
Message Board Posts | Annovis Bio Inc. (OTCMKTS:ANVS)
Subject | By | Source | When |
---|---|---|---|
Price trading | Bayutiger | investorshub | 05/10/2023 10:18:17 PM |
$ANVS The gaining last up | quieter | investorshub | 05/09/2023 5:35:44 AM |
Do we have a winner?Turn around time? | king koopa | investorshub | 05/04/2023 11:45:44 PM |
MomentumIts now | whytestocks | investorshub | 05/01/2023 8:12:02 PM |
$ANVS great article | McMagyar | investorshub | 04/29/2023 2:18:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Annovis Bio Inc. Company Name:
ANVS Stock Symbol:
OTCMKTS Market:
2024-05-17 06:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, provided updates from across the organization and announced fir...
MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today announced successful completion of data cleaning for its ...